Know Cancer

or
forgot password

Measurement of the Folate Receptor in Blood


N/A
18 Years
N/A
Open (Enrolling)
Both
Healthy

Thank you

Trial Information

Measurement of the Folate Receptor in Blood


A method has been developed in the laboratory which has been able to measure FR obtained
from cancer cells in culture that has been added into blood. We would like to study if this
method can measure FR in plasma and serum obtained from patients with ovarian cancer. We
would also like to analyse plasma and serum samples obtained from healthy volunteers to
determine if they have any appreciable levels of FR, which can then be compared to the
measurements obtained from cancer patients.


Inclusion Criteria:



- Patients with stage III/IV ovarian cancer

- healthy volunteers who are staff at the ICR and RMH

Exclusion Criteria:

- patients or healthy volunteers who are unable to give informed consent

- pregnancy

Type of Study:

Observational

Study Design:

N/A

Outcome Measure:

To measure the levels of folate receptor in blood samples obtained from patients with ovarian cancer and from healthy volunteers

Safety Issue:

No

Principal Investigator

Stan Kaye, Professor

Investigator Role:

Principal Investigator

Investigator Affiliation:

Royal Marsden NHS Foundation Trust

Authority:

United Kingdom: Research Ethics Committee

Study ID:

CCR3028

NCT ID:

NCT00838747

Start Date:

September 2008

Completion Date:

July 2011

Related Keywords:

  • Healthy
  • folate receptor
  • blood samples
  • ovarian cancer
  • development of measure of folate receptor in blood samples
  • possible selection of patients for treatment with FR targeted agents

Name

Location